Table 2.
IL‐18 | IL‐18BP | IL‐1β | IL‐1Ra | |
---|---|---|---|---|
LBP | 0.29 ** (0.11, 0.47) | 0.18 (−0.07, 0.42) | −0.04 (−0.37, 0.29) | 0.34 * (0.02, 0.66) |
CCL25 | 0.01 (−0.10, 0.12) | −0.08 (−0.30, 0.13) | 0.06 (−0.20, 0.31) | 0.27 * (0.03, 0.52) |
IFABP | 0.07 (−0.17, 0.02) | 0.02 (−0.19, 0.23) | −0.01 (−0.24, 0.24) | 0.13 (−0.11, 0.37) |
Linear mixed model with markers of inflammasome activation as dependent, time as fixed effect, and biomarker as covariates (LBP, CCL25 or IFABP), and subject as random effect. Data are given as parameter estimates (95%CI) and
P < 0.05,
P < 0.01.
Significant values are in bold.